nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—asthma—atopic dermatitis	0.645	1	CtDrD
Zafirlukast—CYP2C8—Mometasone—atopic dermatitis	0.0277	0.0996	CbGbCtD
Zafirlukast—PTGS1—Diphenhydramine—atopic dermatitis	0.0275	0.0991	CbGbCtD
Zafirlukast—ABCG2—Hydrocortisone—atopic dermatitis	0.0166	0.0597	CbGbCtD
Zafirlukast—CYP2C8—Loratadine—atopic dermatitis	0.0159	0.0572	CbGbCtD
Zafirlukast—CYP3A4—Pimecrolimus—atopic dermatitis	0.0148	0.0533	CbGbCtD
Zafirlukast—CYP2C19—Loratadine—atopic dermatitis	0.0133	0.048	CbGbCtD
Zafirlukast—CYP2C19—Diphenhydramine—atopic dermatitis	0.0133	0.048	CbGbCtD
Zafirlukast—CYP1A2—Diphenhydramine—atopic dermatitis	0.0123	0.0443	CbGbCtD
Zafirlukast—CYP2C9—Loratadine—atopic dermatitis	0.0111	0.0399	CbGbCtD
Zafirlukast—CYP2C9—Diphenhydramine—atopic dermatitis	0.0111	0.0399	CbGbCtD
Zafirlukast—ABCG2—Dexamethasone—atopic dermatitis	0.0103	0.0371	CbGbCtD
Zafirlukast—CYP2D6—Loratadine—atopic dermatitis	0.0101	0.0365	CbGbCtD
Zafirlukast—CYP2D6—Diphenhydramine—atopic dermatitis	0.0101	0.0365	CbGbCtD
Zafirlukast—CYP2C8—Hydrocortisone—atopic dermatitis	0.00884	0.0318	CbGbCtD
Zafirlukast—CYP3A4—Tacrolimus—atopic dermatitis	0.0088	0.0317	CbGbCtD
Zafirlukast—CYP2C19—Prednisone—atopic dermatitis	0.00739	0.0266	CbGbCtD
Zafirlukast—CYP2E1—Dexamethasone—atopic dermatitis	0.00736	0.0265	CbGbCtD
Zafirlukast—CYP3A4—Loratadine—atopic dermatitis	0.00644	0.0232	CbGbCtD
Zafirlukast—CYP3A4—Methylprednisolone—atopic dermatitis	0.00589	0.0212	CbGbCtD
Zafirlukast—CYP2C8—Dexamethasone—atopic dermatitis	0.0055	0.0198	CbGbCtD
Zafirlukast—CYP2C19—Dexamethasone—atopic dermatitis	0.00461	0.0166	CbGbCtD
Zafirlukast—CYP3A4—Triamcinolone—atopic dermatitis	0.00447	0.0161	CbGbCtD
Zafirlukast—CYP2C9—Dexamethasone—atopic dermatitis	0.00383	0.0138	CbGbCtD
Zafirlukast—CYP3A4—Betamethasone—atopic dermatitis	0.00383	0.0138	CbGbCtD
Zafirlukast—CYP3A4—Prednisolone—atopic dermatitis	0.00378	0.0136	CbGbCtD
Zafirlukast—CYP3A4—Hydrocortisone—atopic dermatitis	0.00358	0.0129	CbGbCtD
Zafirlukast—CYP3A4—Prednisone—atopic dermatitis	0.00357	0.0129	CbGbCtD
Zafirlukast—CYP2D6—Dexamethasone—atopic dermatitis	0.0035	0.0126	CbGbCtD
Zafirlukast—CYP3A4—Dexamethasone—atopic dermatitis	0.00223	0.00803	CbGbCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00022	0.0228	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000196	0.0203	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000176	0.0182	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCL22—atopic dermatitis	0.000168	0.0173	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—NPS—atopic dermatitis	0.000156	0.0161	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000156	0.0161	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000153	0.0158	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCL27—atopic dermatitis	0.000149	0.0154	CbGpPWpGaD
Zafirlukast—Injury—Prednisone—atopic dermatitis	0.000148	0.00217	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000148	0.00217	CcSEcCtD
Zafirlukast—Diarrhoea—Loratadine—atopic dermatitis	0.000144	0.00212	CcSEcCtD
Zafirlukast—Oedema—Tacrolimus—atopic dermatitis	0.000144	0.00211	CcSEcCtD
Zafirlukast—Infection—Tacrolimus—atopic dermatitis	0.000143	0.0021	CcSEcCtD
Zafirlukast—Abdominal pain—Mometasone—atopic dermatitis	0.000143	0.0021	CcSEcCtD
Zafirlukast—Body temperature increased—Mometasone—atopic dermatitis	0.000143	0.0021	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000142	0.0147	CbGpPWpGaD
Zafirlukast—Neuropathy peripheral—Prednisolone—atopic dermatitis	0.000141	0.00207	CcSEcCtD
Zafirlukast—Thrombocytopenia—Tacrolimus—atopic dermatitis	0.000141	0.00207	CcSEcCtD
Zafirlukast—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000139	0.00205	CcSEcCtD
Zafirlukast—Dizziness—Loratadine—atopic dermatitis	0.000139	0.00205	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000139	0.0144	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000139	0.0144	CbGpPWpGaD
Zafirlukast—Neuropathy peripheral—Hydrocortisone—atopic dermatitis	0.000138	0.00203	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000136	0.0141	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000135	0.014	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCL17—atopic dermatitis	0.000134	0.0139	CbGpPWpGaD
Zafirlukast—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000134	0.00197	CcSEcCtD
Zafirlukast—Vomiting—Loratadine—atopic dermatitis	0.000134	0.00197	CcSEcCtD
Zafirlukast—Rash—Loratadine—atopic dermatitis	0.000133	0.00195	CcSEcCtD
Zafirlukast—Dermatitis—Loratadine—atopic dermatitis	0.000133	0.00195	CcSEcCtD
Zafirlukast—Headache—Loratadine—atopic dermatitis	0.000132	0.00194	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000131	0.00193	CcSEcCtD
Zafirlukast—Insomnia—Tacrolimus—atopic dermatitis	0.00013	0.00191	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisolone—atopic dermatitis	0.00013	0.00191	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Triamcinolone—atopic dermatitis	0.00013	0.00191	CcSEcCtD
Zafirlukast—Asthenia—Mometasone—atopic dermatitis	0.00013	0.0019	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Methylprednisolone—atopic dermatitis	0.00013	0.0019	CcSEcCtD
Zafirlukast—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000129	0.0019	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisolone—atopic dermatitis	0.000129	0.0019	CcSEcCtD
Zafirlukast—Pruritus—Mometasone—atopic dermatitis	0.000128	0.00188	CcSEcCtD
Zafirlukast—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000127	0.00186	CcSEcCtD
Zafirlukast—Dyspepsia—Tacrolimus—atopic dermatitis	0.000127	0.00186	CcSEcCtD
Zafirlukast—Haemorrhage—Hydrocortisone—atopic dermatitis	0.000126	0.00186	CcSEcCtD
Zafirlukast—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000125	0.00184	CcSEcCtD
Zafirlukast—Nausea—Loratadine—atopic dermatitis	0.000125	0.00184	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000124	0.00182	CcSEcCtD
Zafirlukast—Fatigue—Tacrolimus—atopic dermatitis	0.000124	0.00182	CcSEcCtD
Zafirlukast—Diarrhoea—Mometasone—atopic dermatitis	0.000124	0.00182	CcSEcCtD
Zafirlukast—Pain—Tacrolimus—atopic dermatitis	0.000123	0.00181	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000122	0.0126	CbGpPWpGaD
Zafirlukast—CYSLTR2—Endothelins—MAPK8—atopic dermatitis	0.000121	0.0126	CbGpPWpGaD
Zafirlukast—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00012	0.00177	CcSEcCtD
Zafirlukast—Haemoglobin—Triamcinolone—atopic dermatitis	0.00012	0.00176	CcSEcCtD
Zafirlukast—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000119	0.00175	CcSEcCtD
Zafirlukast—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000119	0.00175	CcSEcCtD
Zafirlukast—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000119	0.00175	CcSEcCtD
Zafirlukast—Haemorrhage—Triamcinolone—atopic dermatitis	0.000119	0.00175	CcSEcCtD
Zafirlukast—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000119	0.00174	CcSEcCtD
Zafirlukast—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000119	0.00174	CcSEcCtD
Zafirlukast—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000119	0.00174	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000118	0.0122	CbGpPWpGaD
Zafirlukast—Neuropathy peripheral—Dexamethasone—atopic dermatitis	0.000118	0.00173	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Betamethasone—atopic dermatitis	0.000118	0.00173	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000118	0.00173	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCL22—atopic dermatitis	0.000116	0.012	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000116	0.012	CbGpPWpGaD
Zafirlukast—Vomiting—Mometasone—atopic dermatitis	0.000115	0.00169	CcSEcCtD
Zafirlukast—Urticaria—Tacrolimus—atopic dermatitis	0.000114	0.00168	CcSEcCtD
Zafirlukast—Rash—Mometasone—atopic dermatitis	0.000114	0.00167	CcSEcCtD
Zafirlukast—Dermatitis—Mometasone—atopic dermatitis	0.000114	0.00167	CcSEcCtD
Zafirlukast—Abdominal pain—Tacrolimus—atopic dermatitis	0.000114	0.00167	CcSEcCtD
Zafirlukast—Body temperature increased—Tacrolimus—atopic dermatitis	0.000114	0.00167	CcSEcCtD
Zafirlukast—Headache—Mometasone—atopic dermatitis	0.000113	0.00166	CcSEcCtD
Zafirlukast—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000112	0.00165	CcSEcCtD
Zafirlukast—Neutropenia—Prednisone—atopic dermatitis	0.00011	0.00161	CcSEcCtD
Zafirlukast—Haemoglobin—Dexamethasone—atopic dermatitis	0.000108	0.00159	CcSEcCtD
Zafirlukast—Haemoglobin—Betamethasone—atopic dermatitis	0.000108	0.00159	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCL11—atopic dermatitis	0.000108	0.0112	CbGpPWpGaD
Zafirlukast—Haemorrhage—Dexamethasone—atopic dermatitis	0.000108	0.00159	CcSEcCtD
Zafirlukast—Haemorrhage—Betamethasone—atopic dermatitis	0.000108	0.00159	CcSEcCtD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000108	0.0112	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—NPS—atopic dermatitis	0.000108	0.0112	CbGpPWpGaD
Zafirlukast—Nausea—Mometasone—atopic dermatitis	0.000107	0.00158	CcSEcCtD
Zafirlukast—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000106	0.00156	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000104	0.00153	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCL27—atopic dermatitis	0.000104	0.0107	CbGpPWpGaD
Zafirlukast—Asthenia—Tacrolimus—atopic dermatitis	0.000103	0.00152	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000103	0.0107	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000103	0.0107	CbGpPWpGaD
Zafirlukast—Angioedema—Prednisolone—atopic dermatitis	0.000103	0.00151	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisone—atopic dermatitis	0.000103	0.00151	CcSEcCtD
Zafirlukast—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000102	0.0015	CcSEcCtD
Zafirlukast—Pruritus—Tacrolimus—atopic dermatitis	0.000102	0.0015	CcSEcCtD
Zafirlukast—Malaise—Prednisolone—atopic dermatitis	0.000102	0.00149	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000101	0.0104	CbGpPWpGaD
Zafirlukast—Angioedema—Hydrocortisone—atopic dermatitis	0.0001	0.00148	CcSEcCtD
Zafirlukast—Back pain—Triamcinolone—atopic dermatitis	0.0001	0.00147	CcSEcCtD
Zafirlukast—Malaise—Hydrocortisone—atopic dermatitis	9.91e-05	0.00146	CcSEcCtD
Zafirlukast—Diarrhoea—Tacrolimus—atopic dermatitis	9.84e-05	0.00145	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	9.83e-05	0.0102	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	9.65e-05	0.00997	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	9.65e-05	0.00997	CbGpPWpGaD
Zafirlukast—Ill-defined disorder—Triamcinolone—atopic dermatitis	9.6e-05	0.00141	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methylprednisolone—atopic dermatitis	9.58e-05	0.00141	CcSEcCtD
Zafirlukast—Dizziness—Tacrolimus—atopic dermatitis	9.51e-05	0.0014	CcSEcCtD
Zafirlukast—Discomfort—Prednisolone—atopic dermatitis	9.47e-05	0.00139	CcSEcCtD
Zafirlukast—Angioedema—Triamcinolone—atopic dermatitis	9.46e-05	0.00139	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisone—atopic dermatitis	9.44e-05	0.00139	CcSEcCtD
Zafirlukast—Angioedema—Methylprednisolone—atopic dermatitis	9.44e-05	0.00139	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisone—atopic dermatitis	9.4e-05	0.00138	CcSEcCtD
Zafirlukast—Myalgia—Hydrocortisone—atopic dermatitis	9.36e-05	0.00138	CcSEcCtD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	9.36e-05	0.00967	CbGpPWpGaD
Zafirlukast—Malaise—Triamcinolone—atopic dermatitis	9.33e-05	0.00137	CcSEcCtD
Zafirlukast—Malaise—Methylprednisolone—atopic dermatitis	9.31e-05	0.00137	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCL17—atopic dermatitis	9.29e-05	0.0096	CbGpPWpGaD
Zafirlukast—Discomfort—Hydrocortisone—atopic dermatitis	9.25e-05	0.00136	CcSEcCtD
Zafirlukast—Oedema—Prednisolone—atopic dermatitis	9.19e-05	0.00135	CcSEcCtD
Zafirlukast—Vomiting—Tacrolimus—atopic dermatitis	9.14e-05	0.00134	CcSEcCtD
Zafirlukast—Rash—Tacrolimus—atopic dermatitis	9.07e-05	0.00133	CcSEcCtD
Zafirlukast—Dermatitis—Tacrolimus—atopic dermatitis	9.06e-05	0.00133	CcSEcCtD
Zafirlukast—Headache—Tacrolimus—atopic dermatitis	9.01e-05	0.00132	CcSEcCtD
Zafirlukast—Oedema—Hydrocortisone—atopic dermatitis	8.97e-05	0.00132	CcSEcCtD
Zafirlukast—Infection—Hydrocortisone—atopic dermatitis	8.91e-05	0.00131	CcSEcCtD
Zafirlukast—Myalgia—Triamcinolone—atopic dermatitis	8.81e-05	0.00129	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCR3—atopic dermatitis	8.81e-05	0.0091	CbGpPWpGaD
Zafirlukast—Arthralgia—Methylprednisolone—atopic dermatitis	8.79e-05	0.00129	CcSEcCtD
Zafirlukast—Myalgia—Methylprednisolone—atopic dermatitis	8.79e-05	0.00129	CcSEcCtD
Zafirlukast—Ill-defined disorder—Dexamethasone—atopic dermatitis	8.71e-05	0.00128	CcSEcCtD
Zafirlukast—Ill-defined disorder—Betamethasone—atopic dermatitis	8.71e-05	0.00128	CcSEcCtD
Zafirlukast—Discomfort—Triamcinolone—atopic dermatitis	8.71e-05	0.00128	CcSEcCtD
Zafirlukast—Discomfort—Methylprednisolone—atopic dermatitis	8.69e-05	0.00128	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL22—atopic dermatitis	8.6e-05	0.00889	CbGpPWpGaD
Zafirlukast—Angioedema—Dexamethasone—atopic dermatitis	8.58e-05	0.00126	CcSEcCtD
Zafirlukast—Angioedema—Betamethasone—atopic dermatitis	8.58e-05	0.00126	CcSEcCtD
Zafirlukast—Nausea—Tacrolimus—atopic dermatitis	8.54e-05	0.00126	CcSEcCtD
Zafirlukast—Malaise—Betamethasone—atopic dermatitis	8.47e-05	0.00124	CcSEcCtD
Zafirlukast—Malaise—Dexamethasone—atopic dermatitis	8.47e-05	0.00124	CcSEcCtD
Zafirlukast—Oedema—Triamcinolone—atopic dermatitis	8.45e-05	0.00124	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCL27—atopic dermatitis	8.44e-05	0.00873	CbGpPWpGaD
Zafirlukast—CYSLTR1—Endothelins—MAPK8—atopic dermatitis	8.42e-05	0.00871	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—CXCL8—atopic dermatitis	8.39e-05	0.00868	CbGpPWpGaD
Zafirlukast—Infection—Triamcinolone—atopic dermatitis	8.39e-05	0.00123	CcSEcCtD
Zafirlukast—Infection—Methylprednisolone—atopic dermatitis	8.37e-05	0.00123	CcSEcCtD
Zafirlukast—Insomnia—Prednisolone—atopic dermatitis	8.31e-05	0.00122	CcSEcCtD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	8.18e-05	0.00845	CbGpPWpGaD
Zafirlukast—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	8.17e-05	0.0012	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	8.17e-05	0.00845	CbGpPWpGaD
Zafirlukast—Insomnia—Hydrocortisone—atopic dermatitis	8.11e-05	0.00119	CcSEcCtD
Zafirlukast—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	8.1e-05	0.00837	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	8.02e-05	0.00829	CbGpPWpGaD
Zafirlukast—Myalgia—Dexamethasone—atopic dermatitis	8e-05	0.00117	CcSEcCtD
Zafirlukast—Myalgia—Betamethasone—atopic dermatitis	8e-05	0.00117	CcSEcCtD
Zafirlukast—Discomfort—Betamethasone—atopic dermatitis	7.9e-05	0.00116	CcSEcCtD
Zafirlukast—Discomfort—Dexamethasone—atopic dermatitis	7.9e-05	0.00116	CcSEcCtD
Zafirlukast—Dyspepsia—Hydrocortisone—atopic dermatitis	7.9e-05	0.00116	CcSEcCtD
Zafirlukast—Pain—Prednisolone—atopic dermatitis	7.86e-05	0.00115	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—NPS—atopic dermatitis	7.85e-05	0.00811	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—TAC1—atopic dermatitis	7.85e-05	0.00811	CbGpPWpGaD
Zafirlukast—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	7.75e-05	0.00114	CcSEcCtD
Zafirlukast—Fatigue—Hydrocortisone—atopic dermatitis	7.73e-05	0.00114	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CXCR3—atopic dermatitis	7.7e-05	0.00796	CbGpPWpGaD
Zafirlukast—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	7.7e-05	0.00113	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	7.68e-05	0.00113	CcSEcCtD
Zafirlukast—Pain—Hydrocortisone—atopic dermatitis	7.67e-05	0.00113	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL27—atopic dermatitis	7.67e-05	0.00793	CbGpPWpGaD
Zafirlukast—Oedema—Dexamethasone—atopic dermatitis	7.67e-05	0.00113	CcSEcCtD
Zafirlukast—Oedema—Betamethasone—atopic dermatitis	7.67e-05	0.00113	CcSEcCtD
Zafirlukast—Insomnia—Triamcinolone—atopic dermatitis	7.64e-05	0.00112	CcSEcCtD
Zafirlukast—Insomnia—Methylprednisolone—atopic dermatitis	7.62e-05	0.00112	CcSEcCtD
Zafirlukast—Infection—Betamethasone—atopic dermatitis	7.62e-05	0.00112	CcSEcCtD
Zafirlukast—Infection—Dexamethasone—atopic dermatitis	7.62e-05	0.00112	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisone—atopic dermatitis	7.59e-05	0.00112	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisolone—atopic dermatitis	7.57e-05	0.00111	CcSEcCtD
Zafirlukast—Thrombocytopenia—Betamethasone—atopic dermatitis	7.5e-05	0.0011	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dexamethasone—atopic dermatitis	7.5e-05	0.0011	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCL11—atopic dermatitis	7.49e-05	0.00774	CbGpPWpGaD
Zafirlukast—Angioedema—Prednisone—atopic dermatitis	7.47e-05	0.0011	CcSEcCtD
Zafirlukast—Dyspepsia—Triamcinolone—atopic dermatitis	7.44e-05	0.00109	CcSEcCtD
Zafirlukast—Dyspepsia—Methylprednisolone—atopic dermatitis	7.42e-05	0.00109	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	7.4e-05	0.00765	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Hydrocortisone—atopic dermatitis	7.39e-05	0.00109	CcSEcCtD
Zafirlukast—Malaise—Prednisone—atopic dermatitis	7.38e-05	0.00108	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	7.34e-05	0.00108	CcSEcCtD
Zafirlukast—Urticaria—Prednisolone—atopic dermatitis	7.3e-05	0.00107	CcSEcCtD
Zafirlukast—Fatigue—Triamcinolone—atopic dermatitis	7.28e-05	0.00107	CcSEcCtD
Zafirlukast—Fatigue—Methylprednisolone—atopic dermatitis	7.27e-05	0.00107	CcSEcCtD
Zafirlukast—Pain—Triamcinolone—atopic dermatitis	7.22e-05	0.00106	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	7.14e-05	0.00739	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	7.14e-05	0.00739	CbGpPWpGaD
Zafirlukast—Urticaria—Hydrocortisone—atopic dermatitis	7.13e-05	0.00105	CcSEcCtD
Zafirlukast—Body temperature increased—Hydrocortisone—atopic dermatitis	7.09e-05	0.00104	CcSEcCtD
Zafirlukast—Abdominal pain—Hydrocortisone—atopic dermatitis	7.09e-05	0.00104	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.03e-05	0.00727	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	7.01e-05	0.00724	CbGpPWpGaD
Zafirlukast—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	6.98e-05	0.00103	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	6.98e-05	0.00103	CcSEcCtD
Zafirlukast—Arthralgia—Prednisone—atopic dermatitis	6.96e-05	0.00102	CcSEcCtD
Zafirlukast—Myalgia—Prednisone—atopic dermatitis	6.96e-05	0.00102	CcSEcCtD
Zafirlukast—Feeling abnormal—Triamcinolone—atopic dermatitis	6.96e-05	0.00102	CcSEcCtD
Zafirlukast—Feeling abnormal—Methylprednisolone—atopic dermatitis	6.95e-05	0.00102	CcSEcCtD
Zafirlukast—Insomnia—Dexamethasone—atopic dermatitis	6.93e-05	0.00102	CcSEcCtD
Zafirlukast—Insomnia—Betamethasone—atopic dermatitis	6.93e-05	0.00102	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	6.89e-05	0.00101	CcSEcCtD
Zafirlukast—Discomfort—Prednisone—atopic dermatitis	6.88e-05	0.00101	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL17—atopic dermatitis	6.88e-05	0.00711	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Prednisolone—atopic dermatitis	6.77e-05	0.000994	CcSEcCtD
Zafirlukast—Dyspepsia—Dexamethasone—atopic dermatitis	6.75e-05	0.000991	CcSEcCtD
Zafirlukast—Dyspepsia—Betamethasone—atopic dermatitis	6.75e-05	0.000991	CcSEcCtD
Zafirlukast—Urticaria—Triamcinolone—atopic dermatitis	6.71e-05	0.000986	CcSEcCtD
Zafirlukast—Urticaria—Methylprednisolone—atopic dermatitis	6.7e-05	0.000984	CcSEcCtD
Zafirlukast—Body temperature increased—Triamcinolone—atopic dermatitis	6.68e-05	0.000981	CcSEcCtD
Zafirlukast—Oedema—Prednisone—atopic dermatitis	6.68e-05	0.000981	CcSEcCtD
Zafirlukast—Abdominal pain—Methylprednisolone—atopic dermatitis	6.66e-05	0.000979	CcSEcCtD
Zafirlukast—Infection—Prednisone—atopic dermatitis	6.63e-05	0.000974	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	6.62e-05	0.000972	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Betamethasone—atopic dermatitis	6.62e-05	0.000972	CcSEcCtD
Zafirlukast—Hypersensitivity—Hydrocortisone—atopic dermatitis	6.61e-05	0.000971	CcSEcCtD
Zafirlukast—Fatigue—Dexamethasone—atopic dermatitis	6.61e-05	0.000971	CcSEcCtD
Zafirlukast—Fatigue—Betamethasone—atopic dermatitis	6.61e-05	0.000971	CcSEcCtD
Zafirlukast—Pain—Dexamethasone—atopic dermatitis	6.55e-05	0.000963	CcSEcCtD
Zafirlukast—Pain—Betamethasone—atopic dermatitis	6.55e-05	0.000963	CcSEcCtD
Zafirlukast—Asthenia—Hydrocortisone—atopic dermatitis	6.44e-05	0.000946	CcSEcCtD
Zafirlukast—Pruritus—Hydrocortisone—atopic dermatitis	6.35e-05	0.000933	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.34e-05	0.00655	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Betamethasone—atopic dermatitis	6.32e-05	0.000928	CcSEcCtD
Zafirlukast—Feeling abnormal—Dexamethasone—atopic dermatitis	6.32e-05	0.000928	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Betamethasone—atopic dermatitis	6.27e-05	0.000921	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dexamethasone—atopic dermatitis	6.27e-05	0.000921	CcSEcCtD
Zafirlukast—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	6.25e-05	0.00646	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Triamcinolone—atopic dermatitis	6.22e-05	0.000914	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CXCL10—atopic dermatitis	6.22e-05	0.00643	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Methylprednisolone—atopic dermatitis	6.21e-05	0.000912	CcSEcCtD
Zafirlukast—Diarrhoea—Hydrocortisone—atopic dermatitis	6.14e-05	0.000902	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCR3—atopic dermatitis	6.1e-05	0.00631	CbGpPWpGaD
Zafirlukast—Urticaria—Dexamethasone—atopic dermatitis	6.09e-05	0.000895	CcSEcCtD
Zafirlukast—Urticaria—Betamethasone—atopic dermatitis	6.09e-05	0.000895	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Prednisone—atopic dermatitis	6.08e-05	0.000894	CcSEcCtD
Zafirlukast—Dizziness—Prednisolone—atopic dermatitis	6.07e-05	0.000893	CcSEcCtD
Zafirlukast—Asthenia—Triamcinolone—atopic dermatitis	6.06e-05	0.000891	CcSEcCtD
Zafirlukast—Body temperature increased—Betamethasone—atopic dermatitis	6.06e-05	0.00089	CcSEcCtD
Zafirlukast—Abdominal pain—Dexamethasone—atopic dermatitis	6.06e-05	0.00089	CcSEcCtD
Zafirlukast—Abdominal pain—Betamethasone—atopic dermatitis	6.06e-05	0.00089	CcSEcCtD
Zafirlukast—Body temperature increased—Dexamethasone—atopic dermatitis	6.06e-05	0.00089	CcSEcCtD
Zafirlukast—Asthenia—Methylprednisolone—atopic dermatitis	6.05e-05	0.000889	CcSEcCtD
Zafirlukast—Insomnia—Prednisone—atopic dermatitis	6.04e-05	0.000887	CcSEcCtD
Zafirlukast—Pruritus—Triamcinolone—atopic dermatitis	5.98e-05	0.000878	CcSEcCtD
Zafirlukast—Pruritus—Methylprednisolone—atopic dermatitis	5.96e-05	0.000876	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL22—atopic dermatitis	5.96e-05	0.00616	CbGpPWpGaD
Zafirlukast—Dizziness—Hydrocortisone—atopic dermatitis	5.93e-05	0.000872	CcSEcCtD
Zafirlukast—Dyspepsia—Prednisone—atopic dermatitis	5.88e-05	0.000863	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCL27—atopic dermatitis	5.85e-05	0.00605	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—TNF—atopic dermatitis	5.84e-05	0.00604	CbGpPWpGaD
Zafirlukast—Rash—Prednisolone—atopic dermatitis	5.79e-05	0.000851	CcSEcCtD
Zafirlukast—Dermatitis—Prednisolone—atopic dermatitis	5.79e-05	0.00085	CcSEcCtD
Zafirlukast—Diarrhoea—Methylprednisolone—atopic dermatitis	5.77e-05	0.000847	CcSEcCtD
Zafirlukast—Fatigue—Prednisone—atopic dermatitis	5.76e-05	0.000846	CcSEcCtD
Zafirlukast—Headache—Prednisolone—atopic dermatitis	5.75e-05	0.000846	CcSEcCtD
Zafirlukast—Vomiting—Hydrocortisone—atopic dermatitis	5.7e-05	0.000838	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	5.66e-05	0.00585	CbGpPWpGaD
Zafirlukast—Rash—Hydrocortisone—atopic dermatitis	5.66e-05	0.000831	CcSEcCtD
Zafirlukast—Dermatitis—Hydrocortisone—atopic dermatitis	5.65e-05	0.00083	CcSEcCtD
Zafirlukast—Headache—Hydrocortisone—atopic dermatitis	5.62e-05	0.000826	CcSEcCtD
Zafirlukast—Dizziness—Triamcinolone—atopic dermatitis	5.59e-05	0.000821	CcSEcCtD
Zafirlukast—Dizziness—Methylprednisolone—atopic dermatitis	5.57e-05	0.000819	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL11—atopic dermatitis	5.54e-05	0.00573	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Prednisone—atopic dermatitis	5.5e-05	0.000808	CcSEcCtD
Zafirlukast—Asthenia—Dexamethasone—atopic dermatitis	5.5e-05	0.000808	CcSEcCtD
Zafirlukast—Asthenia—Betamethasone—atopic dermatitis	5.5e-05	0.000808	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—FCER2—atopic dermatitis	5.47e-05	0.00565	CbGpPWpGaD
Zafirlukast—Gastrointestinal pain—Prednisone—atopic dermatitis	5.46e-05	0.000802	CcSEcCtD
Zafirlukast—Nausea—Prednisolone—atopic dermatitis	5.46e-05	0.000802	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—NPS—atopic dermatitis	5.44e-05	0.00562	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—TAC1—atopic dermatitis	5.44e-05	0.00562	CbGpPWpGaD
Zafirlukast—Pruritus—Betamethasone—atopic dermatitis	5.42e-05	0.000797	CcSEcCtD
Zafirlukast—Pruritus—Dexamethasone—atopic dermatitis	5.42e-05	0.000797	CcSEcCtD
Zafirlukast—Vomiting—Triamcinolone—atopic dermatitis	5.37e-05	0.000789	CcSEcCtD
Zafirlukast—Vomiting—Methylprednisolone—atopic dermatitis	5.36e-05	0.000787	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCL5—atopic dermatitis	5.36e-05	0.00554	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CXCR3—atopic dermatitis	5.34e-05	0.00552	CbGpPWpGaD
Zafirlukast—Nausea—Hydrocortisone—atopic dermatitis	5.33e-05	0.000783	CcSEcCtD
Zafirlukast—Rash—Triamcinolone—atopic dermatitis	5.33e-05	0.000783	CcSEcCtD
Zafirlukast—Dermatitis—Triamcinolone—atopic dermatitis	5.32e-05	0.000782	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL27—atopic dermatitis	5.32e-05	0.00549	CbGpPWpGaD
Zafirlukast—Rash—Methylprednisolone—atopic dermatitis	5.31e-05	0.000781	CcSEcCtD
Zafirlukast—Dermatitis—Methylprednisolone—atopic dermatitis	5.31e-05	0.00078	CcSEcCtD
Zafirlukast—Urticaria—Prednisone—atopic dermatitis	5.3e-05	0.000779	CcSEcCtD
Zafirlukast—Headache—Triamcinolone—atopic dermatitis	5.29e-05	0.000778	CcSEcCtD
Zafirlukast—Headache—Methylprednisolone—atopic dermatitis	5.28e-05	0.000776	CcSEcCtD
Zafirlukast—Abdominal pain—Prednisone—atopic dermatitis	5.28e-05	0.000775	CcSEcCtD
Zafirlukast—Body temperature increased—Prednisone—atopic dermatitis	5.28e-05	0.000775	CcSEcCtD
Zafirlukast—Diarrhoea—Dexamethasone—atopic dermatitis	5.24e-05	0.000771	CcSEcCtD
Zafirlukast—Diarrhoea—Betamethasone—atopic dermatitis	5.24e-05	0.000771	CcSEcCtD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	5.13e-05	0.0053	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL22—atopic dermatitis	5.08e-05	0.00525	CbGpPWpGaD
Zafirlukast—Dizziness—Dexamethasone—atopic dermatitis	5.07e-05	0.000745	CcSEcCtD
Zafirlukast—Dizziness—Betamethasone—atopic dermatitis	5.07e-05	0.000745	CcSEcCtD
Zafirlukast—Nausea—Triamcinolone—atopic dermatitis	5.02e-05	0.000737	CcSEcCtD
Zafirlukast—Nausea—Methylprednisolone—atopic dermatitis	5.01e-05	0.000736	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCR3—atopic dermatitis	4.98e-05	0.00514	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Prednisone—atopic dermatitis	4.92e-05	0.000723	CcSEcCtD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	4.88e-05	0.00505	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	4.88e-05	0.00504	CbGpPWpGaD
Zafirlukast—Vomiting—Betamethasone—atopic dermatitis	4.87e-05	0.000716	CcSEcCtD
Zafirlukast—Vomiting—Dexamethasone—atopic dermatitis	4.87e-05	0.000716	CcSEcCtD
Zafirlukast—Rash—Betamethasone—atopic dermatitis	4.83e-05	0.00071	CcSEcCtD
Zafirlukast—Rash—Dexamethasone—atopic dermatitis	4.83e-05	0.00071	CcSEcCtD
Zafirlukast—Dermatitis—Dexamethasone—atopic dermatitis	4.83e-05	0.000709	CcSEcCtD
Zafirlukast—Dermatitis—Betamethasone—atopic dermatitis	4.83e-05	0.000709	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCR5—atopic dermatitis	4.83e-05	0.00499	CbGpPWpGaD
Zafirlukast—Headache—Dexamethasone—atopic dermatitis	4.8e-05	0.000706	CcSEcCtD
Zafirlukast—Headache—Betamethasone—atopic dermatitis	4.8e-05	0.000706	CcSEcCtD
Zafirlukast—Asthenia—Prednisone—atopic dermatitis	4.79e-05	0.000704	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL17—atopic dermatitis	4.77e-05	0.00493	CbGpPWpGaD
Zafirlukast—Pruritus—Prednisone—atopic dermatitis	4.72e-05	0.000694	CcSEcCtD
Zafirlukast—PTGS1—Overview of nanoparticle effects—IL6—atopic dermatitis	4.72e-05	0.00487	CbGpPWpGaD
Zafirlukast—Diarrhoea—Prednisone—atopic dermatitis	4.57e-05	0.000671	CcSEcCtD
Zafirlukast—Nausea—Dexamethasone—atopic dermatitis	4.55e-05	0.000669	CcSEcCtD
Zafirlukast—Nausea—Betamethasone—atopic dermatitis	4.55e-05	0.000669	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL27—atopic dermatitis	4.53e-05	0.00468	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCR3—atopic dermatitis	4.52e-05	0.00467	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—TAC1—atopic dermatitis	4.44e-05	0.00459	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—NPS—atopic dermatitis	4.44e-05	0.00459	CbGpPWpGaD
Zafirlukast—Dizziness—Prednisone—atopic dermatitis	4.41e-05	0.000649	CcSEcCtD
Zafirlukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	4.39e-05	0.00454	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.39e-05	0.00454	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCR3—atopic dermatitis	4.35e-05	0.0045	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CXCL10—atopic dermatitis	4.31e-05	0.00446	CbGpPWpGaD
Zafirlukast—Vomiting—Prednisone—atopic dermatitis	4.24e-05	0.000624	CcSEcCtD
Zafirlukast—Rash—Prednisone—atopic dermatitis	4.21e-05	0.000618	CcSEcCtD
Zafirlukast—Dermatitis—Prednisone—atopic dermatitis	4.2e-05	0.000618	CcSEcCtD
Zafirlukast—Headache—Prednisone—atopic dermatitis	4.18e-05	0.000614	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL5—atopic dermatitis	4.12e-05	0.00426	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL17—atopic dermatitis	4.06e-05	0.0042	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—NPS—atopic dermatitis	4.03e-05	0.00416	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—TAC1—atopic dermatitis	4.03e-05	0.00416	CbGpPWpGaD
Zafirlukast—Nausea—Prednisone—atopic dermatitis	3.97e-05	0.000583	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCR3—atopic dermatitis	3.95e-05	0.00408	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL11—atopic dermatitis	3.84e-05	0.00397	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.83e-05	0.00396	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—FCER2—atopic dermatitis	3.79e-05	0.00392	CbGpPWpGaD
Zafirlukast—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	3.75e-05	0.00388	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL5—atopic dermatitis	3.74e-05	0.00387	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCL5—atopic dermatitis	3.71e-05	0.00384	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—KIF3A—atopic dermatitis	3.62e-05	0.00374	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL22—atopic dermatitis	3.52e-05	0.00364	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCL10—atopic dermatitis	3.52e-05	0.00363	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCR3—atopic dermatitis	3.45e-05	0.00357	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCR5—atopic dermatitis	3.34e-05	0.00346	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL11—atopic dermatitis	3.27e-05	0.00339	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CMA1—atopic dermatitis	3.27e-05	0.00339	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCL10—atopic dermatitis	3.19e-05	0.0033	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL27—atopic dermatitis	3.14e-05	0.00325	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCR3—atopic dermatitis	3.13e-05	0.00324	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—STAT6—atopic dermatitis	3.08e-05	0.00318	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—TAC1—atopic dermatitis	3.07e-05	0.00318	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—NPS—atopic dermatitis	3.07e-05	0.00318	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCL5—atopic dermatitis	3.03e-05	0.00313	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCR3—atopic dermatitis	3.02e-05	0.00312	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CXCL8—atopic dermatitis	2.92e-05	0.00302	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.91e-05	0.003	CbGpPWpGaD
Zafirlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.9e-05	0.003	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL5—atopic dermatitis	2.86e-05	0.00295	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL17—atopic dermatitis	2.82e-05	0.00291	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—TAC1—atopic dermatitis	2.79e-05	0.00289	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—NPS—atopic dermatitis	2.79e-05	0.00289	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL5—atopic dermatitis	2.75e-05	0.00284	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCR3—atopic dermatitis	2.74e-05	0.00283	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCR5—atopic dermatitis	2.73e-05	0.00282	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.7e-05	0.00279	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCR3—atopic dermatitis	2.67e-05	0.00276	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.66e-05	0.00274	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IFNG—atopic dermatitis	2.65e-05	0.00274	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL5—atopic dermatitis	2.6e-05	0.00268	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—KIF3A—atopic dermatitis	2.51e-05	0.00259	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCR5—atopic dermatitis	2.48e-05	0.00256	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCL10—atopic dermatitis	2.44e-05	0.00252	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NPS—atopic dermatitis	2.38e-05	0.00246	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TAC1—atopic dermatitis	2.38e-05	0.00246	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL1B—atopic dermatitis	2.36e-05	0.00244	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCR3—atopic dermatitis	2.33e-05	0.00241	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL11—atopic dermatitis	2.27e-05	0.00235	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CMA1—atopic dermatitis	2.27e-05	0.00235	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCL10—atopic dermatitis	2.21e-05	0.00229	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL5—atopic dermatitis	2.21e-05	0.00229	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STAT6—atopic dermatitis	2.13e-05	0.00221	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCL5—atopic dermatitis	2.1e-05	0.00217	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CXCL8—atopic dermatitis	2.02e-05	0.00209	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.01e-05	0.00208	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	2e-05	0.00207	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL5—atopic dermatitis	1.91e-05	0.00197	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCR5—atopic dermatitis	1.89e-05	0.00195	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCL10—atopic dermatitis	1.89e-05	0.00195	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR3—atopic dermatitis	1.85e-05	0.00191	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.79e-05	0.00185	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	1.78e-05	0.00184	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	1.78e-05	0.00184	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.75e-05	0.00181	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCR5—atopic dermatitis	1.72e-05	0.00177	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	1.71e-05	0.00177	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NPS—atopic dermatitis	1.65e-05	0.00171	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TAC1—atopic dermatitis	1.65e-05	0.00171	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.65e-05	0.0017	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL5—atopic dermatitis	1.62e-05	0.00168	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCR3—atopic dermatitis	1.62e-05	0.00167	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL2—atopic dermatitis	1.58e-05	0.00163	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.56e-05	0.00161	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL5—atopic dermatitis	1.53e-05	0.00159	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NGF—atopic dermatitis	1.5e-05	0.00155	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCL8—atopic dermatitis	1.5e-05	0.00155	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCR5—atopic dermatitis	1.46e-05	0.00151	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL2—atopic dermatitis	1.43e-05	0.00148	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.42e-05	0.00147	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	1.38e-05	0.00143	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL10—atopic dermatitis	1.31e-05	0.00135	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	1.29e-05	0.00134	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	1.29e-05	0.00134	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GLB1—atopic dermatitis	1.25e-05	0.0013	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NFKBIA—atopic dermatitis	1.24e-05	0.00128	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.21e-05	0.00126	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GLB1—atopic dermatitis	1.2e-05	0.00124	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ADSL—atopic dermatitis	1.2e-05	0.00124	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ADSL—atopic dermatitis	1.15e-05	0.00119	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.14e-05	0.00118	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL5—atopic dermatitis	1.13e-05	0.00116	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL2—atopic dermatitis	1.09e-05	0.00113	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NGF—atopic dermatitis	1.04e-05	0.00108	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCL8—atopic dermatitis	1.04e-05	0.00107	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR5—atopic dermatitis	1.01e-05	0.00105	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL2—atopic dermatitis	9.92e-06	0.00103	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GLB1—atopic dermatitis	9e-06	0.00093	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCL8—atopic dermatitis	8.84e-06	0.000914	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.77e-06	0.000907	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	8.68e-06	0.000898	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ADSL—atopic dermatitis	8.63e-06	0.000892	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NFKBIA—atopic dermatitis	8.6e-06	0.000889	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL2—atopic dermatitis	8.45e-06	0.000874	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL6—atopic dermatitis	8.41e-06	0.000869	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MAPK8—atopic dermatitis	7.78e-06	0.000804	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GLB1—atopic dermatitis	7.78e-06	0.000804	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ADSL—atopic dermatitis	7.46e-06	0.000771	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GLB1—atopic dermatitis	6.94e-06	0.000718	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ADSL—atopic dermatitis	6.65e-06	0.000688	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GLB1—atopic dermatitis	6.38e-06	0.00066	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GLB1—atopic dermatitis	6.33e-06	0.000654	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL8—atopic dermatitis	6.13e-06	0.000634	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADSL—atopic dermatitis	6.12e-06	0.000633	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADSL—atopic dermatitis	6.07e-06	0.000627	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2—atopic dermatitis	5.86e-06	0.000606	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL6—atopic dermatitis	5.83e-06	0.000603	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.67e-06	0.000586	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GLB1—atopic dermatitis	5.41e-06	0.000559	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK8—atopic dermatitis	5.39e-06	0.000557	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADSL—atopic dermatitis	5.19e-06	0.000536	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.06e-06	0.000523	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—atopic dermatitis	4.97e-06	0.000514	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.61e-06	0.000477	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GLB1—atopic dermatitis	4.17e-06	0.000431	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPARA—atopic dermatitis	4.07e-06	0.00042	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADSL—atopic dermatitis	4e-06	0.000414	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.94e-06	0.000407	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARA—atopic dermatitis	3.91e-06	0.000404	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—atopic dermatitis	3.44e-06	0.000356	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARA—atopic dermatitis	2.92e-06	0.000302	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARA—atopic dermatitis	2.52e-06	0.000261	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARA—atopic dermatitis	2.25e-06	0.000233	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.07e-06	0.000214	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARA—atopic dermatitis	2.05e-06	0.000212	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.76e-06	0.000181	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.35e-06	0.00014	CbGpPWpGaD
